Trademark: 88641428
Status Date
Tuesday, April 25, 2023
Registration Number
7037386
Registration Date
Tuesday, April 25, 2023
Filing Date
Thursday, October 3, 2019
Published for Opposition
Tuesday, December 28, 2021
5 Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
1 Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
44 Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals
42 Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Apr 25, 2023
Notice Of Registration Confirmation Emailed
Apr 25, 2023
Registered-Principal Register
Mar 21, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 18, 2023
Allowed Principal Register - Sou Accepted
Feb 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2023
Statement Of Use Processing Complete
Feb 17, 2023
Use Amendment Filed
Feb 21, 2023
Sou Extension 2 Granted
Feb 17, 2023
Sou Extension 2 Filed
Feb 17, 2023
Teas Extension Received
Feb 17, 2023
Teas Statement Of Use Received
Oct 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2022
Sou Extension 1 Granted
Aug 22, 2022
Sou Extension 1 Filed
Sep 1, 2022
Case Assigned To Intent To Use Paralegal
Aug 22, 2022
Teas Extension Received
Feb 22, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 28, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 28, 2021
Published For Opposition
Dec 8, 2021
Notification Of Notice Of Publication E-Mailed
Nov 22, 2021
Law Office Publication Review Completed
Nov 18, 2021
Assigned To Lie
Nov 17, 2021
Approved For Pub - Principal Register
Nov 15, 2021
Assigned To Examiner
Oct 7, 2021
Teas/Email Correspondence Entered
Oct 7, 2021
Correspondence Received In Law Office
Oct 7, 2021
Teas Response To Office Action Received
Jun 4, 2021
Notification Of Non-Final Action E-Mailed
Jun 4, 2021
Non-Final Action E-Mailed
Jun 4, 2021
Non-Final Action Written
Apr 19, 2021
Previous Allowance Count Withdrawn
Mar 28, 2021
Notice Of Allowance Cancelled
Mar 24, 2021
Automatic Update Of Assignment Of Ownership
Feb 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 8, 2021
Teas Extension Received
Oct 27, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 1, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 1, 2020
Published For Opposition
Aug 12, 2020
Notification Of Notice Of Publication E-Mailed
Jul 24, 2020
Approved For Pub - Principal Register
Jul 3, 2020
Teas/Email Correspondence Entered
Jul 2, 2020
Correspondence Received In Law Office
Jul 2, 2020
Teas Response To Office Action Received
Jan 9, 2020
Notification Of Non-Final Action E-Mailed
Jan 9, 2020
Non-Final Action E-Mailed
Jan 9, 2020
Non-Final Action Written
Jan 9, 2020
Non-Final Action Written
Jan 9, 2020
Non-Final Action Written
Jan 8, 2020
Assigned To Examiner
Oct 8, 2019
New Application Office Supplied Data Entered
Oct 7, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
